1991
DOI: 10.1111/j.1365-2710.1991.tb00292.x
|View full text |Cite
|
Sign up to set email alerts
|

Absorption of Low and Therapeutic Doses of Ferric Maltol, a Novel Ferric Iron Compound, in Iron Deficient Subjects Using a Single Dose Iron Absorption Test

Abstract: Ferric maltol is a novel ferric iron compound with potential use as an oral therapy for iron deficiency anaemia. Using a single, low dose iron absorption test we compared absorption of ferric maltol with absorption of ferrous sulphate in 21 iron deficient subjects. Absorption of 10 mg of ferric maltol as either aqueous solution or a single tablet compared favourably with that of an equivalent dose of ferrous sulphate. At a higher, more therapeutic dose of 60 mg elemental iron as tablets, absorption of ferric m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
0

Year Published

1993
1993
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(21 citation statements)
references
References 6 publications
(2 reference statements)
1
20
0
Order By: Relevance
“…Evaluation of ORs in the responder analysis in this study illustrated that it is more difficult to achieve a clinically significant improvement in Hb in patients with mild-to-moderate anemia than it is in patients with more severe anemia 34,35. Although inclusion of only patients with mild-to-moderate anemia was a prerequisite for the incorporation of a placebo control arm in this trial, it is tempting to speculate whether greater treatment effects could be achieved in patients with more severe anemia at baseline, as have been included in previous published studies assessing ferrous sulfate in IBD 17,47…”
Section: Discussionmentioning
confidence: 87%
“…Evaluation of ORs in the responder analysis in this study illustrated that it is more difficult to achieve a clinically significant improvement in Hb in patients with mild-to-moderate anemia than it is in patients with more severe anemia 34,35. Although inclusion of only patients with mild-to-moderate anemia was a prerequisite for the incorporation of a placebo control arm in this trial, it is tempting to speculate whether greater treatment effects could be achieved in patients with more severe anemia at baseline, as have been included in previous published studies assessing ferrous sulfate in IBD 17,47…”
Section: Discussionmentioning
confidence: 87%
“…Disease‐specific quality of life and general quality of life were assessed at randomisation, Week 12, and at 12‐weekly intervals thereafter during the long‐term extension using the IBDQ and the 36‐item Short‐Form (SF‐36) questionnaire, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, the amount of daily maltol intake can be considerable. Maltol has even been suggested to be capable of exerting neuroprotective activity by inhibiting oxidative damage [22 -24], and its iron chelate has been used to treat anaemia in humans [25]. At present the pharmacokinetics of maltol after oral dosing have only been investigated in dogs and indicate rapid and extensive absorbtion, followed by conjugation and rapid excretion [26].…”
Section: Discussionmentioning
confidence: 99%
“…As has been suggested for other nutritional antioxidants [2,42,43], melanoidins may play a role in the antioxidant defence of the gastrointestinal tract, since they are unlikely to be absorbed as such. Maltol may well be absorbed [25], however, and could conceivably exert systemic antioxidant effects.…”
Section: Discussionmentioning
confidence: 99%